AzTrials
AzTrials

DeliriumNCT03351985

The Study of Post-operation Delirium and Prognosis of Cardiac Surgery Patients

An observational study of Delirium, run by Southeast University, China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Delirium is the most common neurological complication of cardiac surgery patients and associated with poor prognosis. In recent years, the important role of quantitative electroencephalogram (qEEG) in brain function monitoring is becoming increasingly prominent. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Delirium
What is being tested?
quantitative electroencephalogram (qEEG)
Type of treatment
Medical device
How many people
56 participants
Where
No sites listed yet
Study dates
1 Dec 2017to 31 Aug 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Adult patients receiving cardiac surgery

Who may be able to join

  • The patients of cardiac surgery aged ≥18 years
  • Signed informed consent

Who cannot join

  • Patients with a history of any neurologic and psychiatric disease
  • Cognitive disorder
  • Stroke history in three years

Trial locations and contacts

No sites are listed yet.

Liu Wenxue, master contact

15751866806

diligent_hi@163.com

Yang Congshan, professor contact

13851462550

ycs7415@163.com

About this study

Official title: the Effect of Quantitative Electroencephalogram (qEEG) in Predictive of Post-operation Delirium and Prognosis of Cardiac Surgery Patients

Delirium is the most common neurological complication of cardiac surgery patients and associated with poor prognosis. In recent years, the important role of quantitative electroencephalogram (qEEG) in brain function monitoring is becoming increasingly prominent. The purpose of this study is to evaluate the effect of qEEG in predictive of post-operation delirium and prognosis of cardiac surgery patients.

Conditions
Delirium
Being tested
quantitative electroencephalogram (qEEG)
Medical subject headings
Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • quantitative electroencephalogram (qEEG)Device

    the patients receive the quantitative electroencephalogram (qEEG) monitoring within 1 hour when they admitted to ICU

Study groups in NCT03351985
Study groupRoleWhat they receive
Delirium GroupThe cardiac surgery patients with delirium receive the quantitative electroencephalogram (qEEG) monitoring within 1 hour when they admitted to ICU
Receives: Device: quantitative electroencephalogram (qEEG)
Non-delirium GroupThe cardiac surgery patients without delirium receive the quantitative electroencephalogram (qEEG) monitoring within 1 hour when they admitted to ICU
Receives: Device: quantitative electroencephalogram (qEEG)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. amplitude integrated electroencephalogram (aEEG)

    the electroencephalogram amplitude of cardiac surgery patients assessed by quantitative electroencephalogram when admitted to intensive care unit

    Measured: 24 hours

Secondary outcomes (12)
  1. alpha frequency band energy

    the percentage of alpha frequency band of cardiac surgery patients assessed by quantitative electroencephalogram when admitted to intensive care unit

    Measured: 24 hours

  2. beta frequency band energy

    the percentage of beta frequency band of cardiac surgery patients assessed by quantitative electroencephalogram when admitted to intensive care unit

    Measured: 24 hours

  3. theta frequency band energy

    the percentage of theta frequency band of cardiac surgery patients assessed by quantitative electroencephalogram when admitted to intensive care unit

    Measured: 24 hours

  4. delta frequency band energy

    the percentage of delta frequency band of cardiac surgery patients assessed by quantitative electroencephalogram when admitted to intensive care unit

    Measured: 24 hours

  5. alpha variability

    the variability of alpha frequency band of cardiac surgery patients assessed by quantitative electroencephalogram when admitted to intensive care unit

    Measured: 24 hours

  6. arterial oxygen saturation (SaO2)

    the level of arterial oxygen saturation (SaO2) of cardiac surgery patients when admitted to intensive care unit

    Measured: 24 hours

  7. central venous oxygen saturation (ScvO2)

    the level of central venous oxygen saturation(ScvO2) of cardiac surgery patients when admitted to intensive care unit

    Measured: 24 hours

  8. neuron specific enolase (NSE)

    the level of neuron specific enolase (NSE) of cardiac surgery patients when admitted to intensive care unit

    Measured: 24 hours

  9. interleukin-6 (IL-6)

    the level of interleukin-6 (IL-6) of cardiac surgery patients when admitted to intensive care unit

    Measured: 24 hours

  10. troponin i (TNI)

    the level of troponin i (TNI) of cardiac surgery patients when admitted to intensive care unit

    Measured: 24 hours

  11. high-sensitivity C-reactive protein (hs-CRP)

    the level of high-sensitivity C-reactive protein (hs-CRP) of cardiac surgery patients when admitted to intensive care unit

    Measured: 24 hours

  12. N-terminal pro brain natriuretic peptide (NT-pro-BNP)

    the level of N-terminal pro brain natriuretic peptide (NT-pro-BNP) of cardiac surgery patients when admitted to intensive care unit

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2017
  2. Study start1 Dec 2017 (estimated)
  3. Primary completion30 Jun 2018 (estimated)
  4. Study completion31 Aug 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
56 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03351985
Sponsor's protocol ID
2017ZDSYLL054-P01
Status last verified
Nov 2017
First submitted
14 Nov 2017
Last updated
24 Nov 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Guo Z, Wan W, Liu W, Liu L, Yang Y, Yang C, Cui X. Quantitative electroencephalography predicts postoperative delirium in adult cardiac surgical patients from a prospective observational study. Sci Rep. 2024 Dec 28;14(1):31101. doi: 10.1038/s41598-024-82422-7.

    PubMed 39730694

Questions about this trial

What is this clinical trial studying?

An observational study of Delirium, run by Southeast University, China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Liu Wenxue, master (15751866806, diligent_hi@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

amplitude integrated electroencephalogram (aEEG) (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03351985, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in